Clinical Research Directory
Browse clinical research sites, groups, and studies.
Zirconia-Reinforced Glass Ionomer Versus Injectable Giomer in Class V Restorations
Sponsor: Cairo University
Summary
This randomized controlled clinical trial aims to compare the clinical performance of zirconia-reinforced glass ionomer and injectable giomer restorations in Class V carious lesions among controlled type II diabetic against non-diabetics. One hundred Class V restorations will be allocated equally into four parallel groups according to restorative material and diabetic status. Clinical performance will be evaluated at baseline, 6, 12, and 18 months using the modified United States Public Health Service (USPHS) criteria. The primary outcome is restoration retention, while secondary outcomes include marginal adaptation, marginal discoloration, secondary caries, and postoperative sensitivity.
Official title: Clinical Performance of Zirconia-Reinforced Glass Ionomer Versus Injectable Giomer in Class V Restorations of Diabetic and Non Diabetic Patients: 18 Months Controlled Clinical Trial
Key Details
Gender
All
Age Range
22 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2027-01
Completion Date
2029-01
Last Updated
2026-07-28
Healthy Volunteers
No
Conditions
Interventions
Zirconomer
Zirconia-reinforced glass ionomer restorative material (SHOFU)
Beautifil Flow Plus X
Injectable giomer restorative material incorporating S-PRG technology (SHOFU)